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Introduction: Soluble epoxide hydrolase (sEH) inhibitors have been shown to 
effectively increase the levels of epoxyeicosatrienoic acids and reduce the levels of 
dihydroxyeicosatrienoic acids, which may be translated to therapeutic potentials for 
hypertension, diabetes, stroke, dyslipidemia, pain, immunological disorders, eye 
diseases, neurological diseases and other indications. Since most sEH inhibitors have 
poor pharmacokinetic properties, development of novel inhibitors is a great deal of 
attention. 
Methods and Results: Based on the structure activity relationship of soluble 
epoxide hydrolase inhibitors and docking studies, some novel compounds with 
amide moiety and triazole ring as a first and second pharmacophore respectively 
were designed. These structures were synthesized through 4 step reaction with 
proper yields. Initially, 4-nitrobenzoyl chloride was reacted with hydrazine hydrate 
and then in the presence of benzonitrile and catalytic amounts of copper iodide, 
1,2,4-triazole was closed. Final products were obtained by reduction of nitro group 
and reaction with various benzoyl chlorides. Docking studies on the designed sEH 
inhibitors confirm that the amide groups of the analogues fit properly in the active 
site of sEH and have a suitable distance from the amino acids of Tyr466 and Asp335 
for effective hydrogen bonding. These novel compounds were synthesized in 
appropriate yield and their structure was approved by instrumental methods 
including IR, Mass, HNMR and CNMR spectroscopies. 
Conclusions: In conclusion, some novel amide-based soluble epoxide hydrolase 
enzyme inhibitors with a 1,2,4-tri azole as a novel secondary pharmacophore were 
designed, synthesized and structurally approved by IR, NMR and Mass spectra. 
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